Click on the title to go to PubMed
- The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries.
- Perceived Risks Contra Benefits of Using Biosimilar Drugs in Ulcerative Colitis: Discrete Choice Experiment among Gastroenterologists.
- Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists
- Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries.in reimbursement decisions in three European countries.
- Preferences of Hungarian consumers for quality, access and price attributes of health care services.